Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor
January 25, 2023 04:00 ET | AKAMPION
- Claus Andersson, PhD, joins Rewind´s Board of Directors Leuven, Belgium, January 25, 2023 --- Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated...
Magstim TMS OCD FDA Cleared photo
FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
January 18, 2023 13:05 ET | Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...
Zai Lab Appoints Michel Vounatsos To Its Board of Directors
January 09, 2023 07:30 ET | Zai Lab Limited
SHANGHAI and CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Michel Vounatsos has been appointed to its Board of Directors,...
Reset-Logo for GNW.jpg
Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
January 05, 2023 08:00 ET | Reset Pharmaceuticals Inc.
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental...
SBMT Logo.png
9th Annual “N20” Neuroscience20 (Brain, Spine, and Mental Health) Summit to Shed Light On $16T+ Global Cost of Neuro-psychiatric Disorders
November 10, 2022 21:43 ET | Society for Brain Mapping & Therapeutics
LOS ANGELES, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Launched nine years ago, Neuroscience20 (N20) educates global leaders and Group of Twenty (G20) leaders about the cost of neurological, spine, and...
Reset-Logo for GNW.jpg
Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors
November 02, 2022 08:00 ET | Reset Pharmaceuticals Inc.
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel...
SportGait and Carrick Institute
SportGait Partners With the Carrick Institute, Incorporating Cutting-Edge Concussion Support and Recovery Technology
October 26, 2022 14:00 ET | SportGait
WILMINGTON, N.C., Oct. 26, 2022 (GLOBE NEWSWIRE) -- SportGait, the brain wellness and medical technology company, proudly announced today a partnership with The Carrick Institute, world leader in...
Omniscient Neurotechnology Appoints Two New Members to Its Board of Directors
October 24, 2022 08:30 ET | Omniscient Neurotechnology
SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara...
Human Augmentation Market Size Worth $498+ Billion, Globally, by 2028 at 23% CAGR - Exclusive Study by The Insight Partners
October 11, 2022 09:17 ET | The Insight Partners
New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Human Augmentation Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product Type (Wearable...
Axsome Logo.png
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
September 29, 2022 07:28 ET | Axsome Therapeutics, Inc.
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...